CBT
Get informed when a big investor buys or sells
+ FollowOvervalued by 16.7% based on the discounted cash flow analysis.
| Market cap | $4.52 Billion |
|---|---|
| Enterprise Value | $5.60 Billion |
| Dividend Yield | $2.27 (2.08%) |
| Earnings per Share | $6.07 |
| Beta | 0.78 |
| Outstanding Shares | 52,000,000 |
| P/E Ratio | 15.97 |
|---|---|
| PEG | -57.73 |
| Price to Sales | 1.25 |
| Price to Book Ratio | 2.66 |
| Enterprise Value to Revenue | 1.57 |
| Enterprise Value to EBIT | 9.6 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.85 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6478▼ 98.86% |
|---|---|
| Total Calls | 42,300▲ 126.20% |
| Total Puts | 27,400▼ 10.46% |
Holdings and activity of institutional investors.
| Ownership % | 96.70%▼ 0.72% |
|---|---|
| Total Invested | $3.84B▲ 12.54% |
| Investors Holding | 372▲ 6.00% |
No data
This committee provides the official revenue estimates for all tax legislation, directly influencing corporate tax structures and financial planning for companies like Cabot.
As the primary tax-writing committee, it directly impacts Cabot's corporate tax burden. Its control over trade policy (tariffs, import/export regulations) is also critical for a global manufacturer dealing with raw materials and finished goods.
This committee directly regulates the EPA, which imposes significant environmental compliance costs and standards on chemical manufacturers. Infrastructure projects it oversees can also drive demand for Cabot's products.